Forma Therapeutics, Inc.

Company History
FORMA Therapeutics is integrating transformative biology and chemistry to unlock the best targets and pathways that genomics medicine has revealed. FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub, Michael Foley, each of the Broad Institute of Harvard and MIT and leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of targeted breakthrough oncology drugs. FORMA is a global company headquartered in Cambridge, MA with additional research operations in Connecticut, Singapore and Beijing.

Current Investors/Backers
Forma Therapeutics, Inc. is backed by pharmaceutical giant Novartis and its BioVenture fund.

For more information on Forma Therapeutics, Inc., please visit their web site at www.formatherapeutics.com.